Sai Life Sciences Ltd

Sai Life Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Sai Life Sciences Ltd

₹ 916 2.35%
10 Feb 9:55 a.m.
sailife.com BSE: 544306 NSE: SAILIFE
About

Incorporated in 1999, Sai Life Sciences
Ltd carries out contract research and manufacturing activities for customers
engaged in pharmaceutical and bio
technology industries[1]

Key Points

Business Profile[1]
Sai Life Sciences is an integrated CRDMO (Contract Research, Development and Manufacturing Organization) delivering end-to-end services across the pharmaceutical lifecycle from early drug discovery to commercial manufacturing.

Website BSE NSE
  • Market Cap ₹ 19,342 Cr.
  • Current Price ₹ 916
  • High / Low ₹ 984 / 635
  • Stock P/E 57.7
  • Book Value ₹ 109
  • Dividend Yield 0.00 %
  • ROCE 14.1 %
  • ROE 11.0 %
  • Face Value ₹ 1.00
Edit ratios

Pros

  • Company has reduced debt.
  • Company is expected to give good quarter

Cons

  • Stock is trading at 8.20 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has a low return on equity of 8.54% over last 3 years.
  • Working capital days have increased from 43.4 days to 68.8 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Part of BSE 500 BSE Healthcare Nifty 500 BSE Allcap BSE 250 SmallCap Index

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
373 428 264 382 429 567 483 527 549
279 301 240 281 317 413 370 387 370
Operating Profit 94 127 25 101 111 154 113 140 179
OPM % 25% 30% 9% 26% 26% 27% 23% 27% 33%
11 4 8 10 9 10 10 15 0
Interest 22 19 20 19 22 9 11 8 8
Depreciation 28 28 28 33 31 34 34 36 41
Profit before tax 54 83 -15 58 68 120 78 111 130
Tax % 26% 26% -25% 25% 25% 25% 25% 25% 25%
40 62 -11 44 51 90 58 83 98
EPS in Rs 2.45 4.32 2.80 3.95 4.62
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
695 725 751 841 1,157 1,419 1,642 2,126
520 556 587 716 990 1,131 1,248 1,540
Operating Profit 175 170 164 125 167 288 394 586
OPM % 25% 23% 22% 15% 14% 20% 24% 28%
6 18 27 28 27 29 36 35
Interest 24 21 32 51 74 81 72 36
Depreciation 44 52 72 80 88 107 126 145
Profit before tax 112 114 88 22 33 129 232 440
Tax % 35% 30% 25% 30% 26% 26% 25%
73 80 65 16 24 95 173 329
EPS in Rs 8.32 15.69
Dividend Payout % 0% 0% 0% 444% 279% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: 18%
3 Years: 25%
TTM: 41%
Compounded Profit Growth
10 Years: %
5 Years: 17%
3 Years: 242%
TTM: 131%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: 25%
Return on Equity
10 Years: %
5 Years: 7%
3 Years: 9%
Last Year: 11%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Sep 2025
Equity Capital 16 16 18 18 18 18 21 21
Reserves 700 778 850 873 895 993 2,147 2,282
250 304 637 752 869 868 287 354
246 291 312 464 349 361 682 644
Total Liabilities 1,212 1,389 1,816 2,106 2,131 2,240 3,137 3,301
373 617 659 701 923 1,074 1,378 1,512
CWIP 116 79 236 345 151 107 124 115
Investments 0 22 63 64 80 80 114 114
722 671 858 996 977 979 1,521 1,559
Total Assets 1,212 1,389 1,816 2,106 2,131 2,240 3,137 3,301

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
127 109 -26 88 221 251 330
-158 -259 -279 -95 -111 -190 -565
268 -1 304 81 -190 -85 314
Net Cash Flow 237 -152 -2 75 -80 -24 80

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 123 136 98 103 87 67 78
Inventory Days 86 77 124 185 123 73 96
Days Payable 208 247 244 284 176 114 270
Cash Conversion Cycle 0 -34 -21 4 35 25 -96
Working Capital Days 55 32 60 49 42 20 69
ROCE % 13% 9% 4% 6% 11% 14%

Shareholding Pattern

Numbers in percentages

Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
35.23% 35.16% 35.15% 34.95% 34.70%
11.72% 12.36% 14.57% 22.50% 21.41%
11.95% 13.26% 21.64% 29.92% 31.41%
41.08% 39.21% 28.64% 12.65% 12.49%
No. of Shareholders 1,81,1221,40,6771,26,3801,19,7051,14,820

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls